Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2018-11-14T18:17:53+00:00

The Dimerix Limited Clinical Trials – ACTION for Diabetic Kidney Disease and ACTION for Focal Segmental Glomerulosclerosis – Are Now Open!

Click Here For More Information

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

Analyst Coverage: Dimerix Appears on Bulls, Bears and Brokers series

https://youtu.be/G2n87j7lu3U   Dimerix is mentioned by Tony Locantro at 7:17.

ASX: Dimerix Awarded $50,000 Innovation Connections Grant

More information available here

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation